Clinical Trial Update: Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tariquidar with docetaxel in patients with lung cancer, ovarian cancer, cervical cancer, and renal cell carcinoma. The trial is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Lung Cancer
• Ovarian Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Tariquidar (tariquidar)
• Taxotere (docetaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Neoplasms, Ovarian Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2012-10-12